Ken Griffin Iqvia Holdings Inc. Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$206.81 - $251.55 $6.16 Million - $7.5 Million	-29,800 Reduced 44.68%	36,900 $8.74 Million
Q2 2024 Aug 14, 2024	SELL	$211.18 - $248.87 $12.6 Million - $14.9 Million	-59,700 Reduced 47.23%	66,700 $14.1 Million
Q1 2024 May 15, 2024	BUY	$208.23 - $259.1 $13 Million - $16.1 Million	62,200 Added 96.88%	126,400 $32 Million
Q4 2023 Feb 14, 2024	BUY	$177.16 - $232.73 $1.86 Million - $2.44 Million	10,500 Added 19.55%	64,200 $14.9 Million
Q3 2023 Nov 14, 2023	BUY	$196.75 - $231.96 $944,400 - $1.11 Million	4,800 Added 9.82%	53,700 $10.6 Million
Q2 2023 Aug 14, 2023	BUY	$183.66 - $224.77 $2.68 Million - $3.28 Million	14,600 Added 42.57%	48,900 $11 Million
Q1 2023 May 15, 2023	SELL	$188.0 - $240.65 $4.87 Million - $6.23 Million	-25,900 Reduced 43.02%	34,300 $6.82 Million
Q4 2022 Feb 14, 2023	SELL	$172.45 - $226.53 $3.19 Million - $4.19 Million	-18,500 Reduced 23.51%	60,200 $12.3 Million
Q3 2022 Nov 14, 2022	BUY	$181.14 - $248.26 $5.07 Million - $6.95 Million	28,000 Added 55.23%	78,700 $14.3 Million

1,137

142M

828K

951K

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $35.5B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.